Target intelligence / Profile preview

Sodium-dependent serotonin transporter (Rattus norvegicus) (SERT)

Target
SERT
Molecular classification
Transporter, Solute carrier family 6, Neurotransmitter transporter
01

Overview

The Sodium-dependent serotonin transporter (SERT), specifically the Rattus norvegicus ortholog, is a member of the solute carrier family 6 (SLC6) and plays a critical role in regulating serotonergic neurotransmission (UniProt P31652). It functions by transporting serotonin (5-HT) from the extracellular space back into the presynaptic terminal, utilizing the electrochemical gradient of sodium and chloride ions (NCBI Gene 25553). This reuptake mechanism is the principal means of terminating the action of serotonin at the synapse, thereby influencing mood, sleep, appetite, and cognition (PubMed 1550558). In pharmacological research, the rat SERT is a primary model for studying the binding kinetics and efficacy of antidepressants, such as Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine and sertraline (StatPearls NBK532290). Dysfunctional serotonin transport is linked to the pathophysiology of major depressive disorder, anxiety, and obsessive-compulsive disorder, making SERT one of the most significant targets in neuropsychiatry (PubMed 10446301). Additionally, SERT is expressed in non-neuronal tissues such as blood platelets and the enteric nervous system, where it modulates peripheral serotonin levels (PubMed 11518344).

Other names
5-HTT5-hydroxytryptamine transporterSolute carrier family 6 member 4Slc6a4HTT
02

Mechanism of action

Inhibition of serotonin reuptake from the synaptic cleft into the presynaptic neuron, thereby increasing extracellular serotonin concentrations and prolonging serotonergic signaling (StatPearls NBK532290).

03

Biological functions

Serotonin reuptakeNeurotransmission regulationSynaptic homeostasisSodium-dependent transport
04

Disease associations

Major depressive disorderAnxiety disorderObsessive-compulsive disorderPost-traumatic stress disorderIrritable bowel syndrome
05

Safety considerations

Serotonin syndrome (StatPearls NBK482377)Sexual dysfunctionGastrointestinal distressWithdrawal/Discontinuation syndromeIncreased risk of bleedingHyponatremia
06

Interacting drugs

Fluoxetine

10 more in the full profile.

07

Biomarkers

Platelet serotonin levels (PubMed 11518344)SERT occupancy via PET/SPECT imaging using ligands like [11C]DASB (PubMed 15654394)Cerebrospinal fluid 5-HIAA levels

Beyond the preview

Go deeper on Sodium-dependent serotonin transporter (Rattus norvegicus) (SERT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent serotonin transporter (Rattus norvegicus) (SERT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call